United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 10, 2026 · Filed Jul 13, 2026

On Jul 10, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$544.60 for US$5.17M under a trading plan, leaving 40,513 shares. Filed Jul 13, 2026 (Form 4).

Sold
9,500 shares
Price
US$544.60 average (US$540.37 to US$553.47)
Value
US$5.17M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 10, 2026Common StockOption exercise9,500US$135.4250,013Direct
Jul 10, 2026Common StockSale600US$540.3749,413Direct
Jul 10, 2026Common StockSale970US$541.4748,443Direct
Jul 10, 2026Common StockSale1,870US$542.4946,573Direct
Jul 10, 2026Common StockSale676US$543.3445,897Direct
Jul 10, 2026Common StockSale364US$544.5445,533Direct
Jul 10, 2026Common StockSale1,524US$545.5444,009Direct
Jul 10, 2026Common StockSale1,438US$546.4242,571Direct
Jul 10, 2026Common StockSale1,578US$547.1740,993Direct
Jul 10, 2026Common StockSale400US$548.4440,593Direct
Jul 10, 2026Common StockSale80US$553.4740,513Direct

Source

View original at SEC

Related